Advertisement

Pharmacy

On May 21, a federal judge approved Rite Aid’s bankruptcy plan to close stores and sell most of its pharmacy assets to other national chains, according to court documents reviewed by Becker’s.  CVS, Walgreens, and grocery store chains Albertsons, Kroger,…

In the first quarter of 2025, there were 39,111 job postings for pharmacy technicians nationwide, according to a May 14 report from the American Association of Colleges of Pharmacy.  This marks a slight decline from the same period in 2024,…

President Donald Trump recently signed an executive order aimed at lowering prescription drug prices. However, experts told KFF Health News the policy’s rollout reveals a slow, conditional path that hinges on drugmakers’ cooperation and potential future rulemaking.  Here are five…

Advertisement

Walgreens has opened a central pharmacy center in Brooklyn Park, Minn., aimed at streamlining prescription fulfillment and freeing up pharmacists’ time.  The micro-fulfillment center is equipped with robotic technology to process, dispense and ship medications, according to a May 20…

Health systems nationwide are making investments in specialty pharmacy and centralized pharmacy services to help enhance care for patients, streamline operations and improve medication access.  Here are some of the systems that plan to launch specialty pharmacies in late 2025…

The American Hospital Association is raising alarms over the potential fallout from a series of recently implemented tariffs, warning it could negatively impact patient care and worsen existing drug shortages.  AHA Chair Tina Freese Decker warned that tariffs on critical…

HHS is taking “immediate steps” to implement President Donald Trump’s executive order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients — a key initiative aimed at reducing healthcare costs. The department said it has established specific “pricing targets” that pharmaceutical…

The FDA has approved Novavax’s COVID-19 vaccine, Nuvavoxid, for use in adults 65 and older and in individuals ages 12-64 who have at least one underlying health condition.  The approval is based on phase 3 clinical trial data that showed…

Advertisement